Albireo Pharma Inc (NASDAQ:ALBO)

Delayed Data
As of May 23
 +0.18 / +0.55%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 50.00, with a high estimate of 92.00 and a low estimate of 41.00. The median estimate represents a +50.92% increase from the last price of 33.13.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Albireo Pharma Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 20

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -484.44%
Growthannually 2.96%


Growthquarterly -100.00%
Growthannually 1,459,285.50%
Key to the earnings and sales forecast charts.